Altimmune (ALT) Tax Provisions (2012 - 2025)

Altimmune (ALT) reported Tax Provisions of -$681000.0 for Q1 2025, down 245.69% quarter-over-quarter from -$197000.0 in Q3 2022.

Altimmune (ALT) Tax Provisions (2012 - 2025) Analysis & Trends

Altimmune (ALT) has 11 years of Tax Provisions data on file, last reported at -$681000.0 in Q1 2025.

Tax Provisions for Q1 2025 came in at -$681000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$681000.0 (changed N/A YoY), and the FY2025 annual result was -$681000.0, changed N/A from the prior year.
Tax Provisions declined to -$681000.0 in Q1 2025 per ALT's latest filing, from -$197000.0 in the prior quarter.
Over five years, Tax Provisions peaked at -$197000.0 in Q3 2022 and troughed at -$681000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-11.20 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	216,000.00
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-859,000.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	221.50 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Altimmune	336.67 Mn	336.67 Mn	-	-

Download Data